Denemek ALTIN - Özgür
Traditional Medicines & Covid-19
Bio Spectrum
|June 2020
Allopathic drugs are already being tried to treat COVID-19 but even with promising results these drugs always comes with some side-effects unlike in case of traditional system of medicines.
India has perhaps the world’s oldest as well as largest tradition of systems of medicine. The term Indian Systems of Medicine covers both the systems which originated in India as well as outside but got adopted in India in course of time. These systems are Ayurveda, Siddha, Unani, Homoeopathy, Yoga, and Naturopathy. They have become a part of the culture and traditions of India. India with its strong base in traditional knowledge on herbal medicine and vast plant biodiversity has a great potential in this sector which can be examined in the current pandemic situation where the entire world has been majorly affected with COVID-19.
At a time when the world is looking for preventive and therapeutic solutions against coronavirus spread and its effects, examining the ways in which traditional medicine system can play a role can be crucial. Allopathic drugs are already being tried to treat COVID-19 but even with promising results these drugs always comes with some side-effects unlike in case of traditional system of medicines.
How promising it can be?
Ayurveda has spoken of epidemics in great details. Acharya Chakrapani has written on simultaneous and widespread manifestation of disease with the same set of symptoms throughout a community.
Bu hikaye Bio Spectrum dergisinin June 2020 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Bio Spectrum'den DAHA FAZLA HİKAYE
Bio Spectrum
Telangana targets Rs 1 lakh crore investments in Life Sciences by 2030
Telangana has set an ambitious target of attracting Rs 1 lakh crore in new investments in the Life Sciences sector by 2030, aiming to generate employment for five lakh people, as per Minister for IT and Industries Duddilla Sridhar Babu.
1 min
December 2025
Bio Spectrum
Siegwerk makes entry into pharma packaging segment in India with Rs 350 Cr investment
German firm Siegwerk has announced its strategic entry into the pharmaceutical packaging segment in India, reinforcing its commitment to consumer safety.
1 min
December 2025
Bio Spectrum
Karnataka unveils Rs 600+ Cr 'Deep Tech Decade' initiative
The Government of Karnataka has announced an investment of over Rs 600 crore to power the state's \"Deep Tech Decade,\" with the goal of establishing Karnataka as the Deep Tech Capital of India.
1 min
December 2025
Bio Spectrum
Alkem Foundation and IIT-B to set up advanced research centre for immuno- therapeutics and regenerative medicines
Alkem Foundation, the Corporate Social Responsibility (CSR) arm of Mumbai-based Alkem Laboratories, and Indian Institute of Technology Bombay (IIT-B) have announced a strategic collaboration to set up a first- of-its-kind research centre in India dedicated to immuno- therapeutics and regenerative medicines.
1 min
December 2025
Bio Spectrum
MedGenome makes majority investment in Gujarat's Green Cross
Bengaluru-based MedGenome, a leading global genomics-driven diagnostics and research services company, has announced a majority investment in Gujarat-headquartered pathology laboratory chain, Green Cross Genetics Lab.
1 min
December 2025
Bio Spectrum
ANRF, in collaboration with ICMR and Gates Foundation, launches Maha MedTech Mission
Anusandhan National Research Foundation (ANRF), in collaboration with the Indian Council of Medical Research (ICMR) and the Gates Foundation, has launched the Mission for Advancement in High-Impact Areas (MAHA)-Medical Technology (hm MedTech).
1 min
December 2025
Bio Spectrum
Re-Pivoting Pharma Strategy
The United States has effectively shut the door on several Indian medicines after President Donald Trump imposed a steep 100 per cent duty on branded and patented drugs. The tariff, effective from October 1, triggered trade and policy uncertainty across the global pharmaceutical industry. Till then, medicines had largely been spared from the Trump administration's tariff regime. The abrupt move forced drug exporters to the US to rethink their strategies. India, however, remained insulated to some extent because of the nature of its export basket and presence of manufacturing units of some Indian companies in the US.
2 mins
December 2025
Bio Spectrum
Breaking Ground in Clinical Trials: India's Innovation Imperative
For decades, India has been a global powerhouse in pharmaceutical manufacturing. Yet in clinical trials, the crucial bridge between laboratory discoveries and patient access, the country’s performance has lagged behind its industrial capabilities.
5 mins
November 2025
Bio Spectrum
MOFs for Next-Gen Therapies
Susumu Kitagawa, Richard Robson and Omar M Yaghi have been awarded the Nobel Prize in Chemistry 2025 for the development of a new type of molecular architecture called metal-organic frameworks (MOFs), opening new avenues for applications such as drug delivery, biomedical imaging and personalised medicine.
2 mins
November 2025
Bio Spectrum
We aim to make bio-based industries a key pillar of the state's GSDP by 2030: Kerala CM
Kerala recently set the spotlight on its growing life sciences ecosystem with Bio Connect 3.0 – International Life Sciences Conclave & Expo, held on October 9 & 10, 2025, in Thiruvananthapuram. The event brought together global innovators, researchers, investors, and industry leaders to explore opportunities, collaborations, and advancements across biotechnology, healthcare, digital health, and allied sectors. Organised by the Kerala Life Sciences Industries Park (KLIP) and the Kerala State Industrial Development Corporation (KSIDC), this conclave featured thought-provoking discussions, visionary keynote sessions, and cutting-edge technology showcases.
3 mins
November 2025
Translate
Change font size

